University of Pennsylvania Scientists Receive ACGT Grant to Accelerate CAR T-Cell Clinical Trial for Prostate Cancer

Feb 03, 2020

Novel Gene Therapy Approach to Prostate Cancer Already Seeing Results in Clinical Trial and May Have Impact on Other Solid Tumor Cancers

STAMFORD, Conn. — A scientific team is developing a new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at the Abramson Cancer Center of the University of Pennsylvania (Philadelphia,

Read More

St. Jude Children’s Research Hospital Scientist Receives ACGT Grant to Accelerate Gene Therapy Treatment for Pediatric Sarcoma

Feb 03, 2020

Approach will use Genetically Engineered Immune Cells to Attack Pediatric Sarcoma

STAMFORD, Conn. — An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children’s Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy (ACGT).

Read More

ACGT Opens 2020 Cancer Cell & Gene Therapy Research Grant Program Focusing on Solid Tumors – Glioblastoma and Pancreatic Cancers

Nov 12, 2019

STAMFORD, Conn., Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit organization dedicated exclusively to funding cancer cell and gene therapy research, announced the availability of grants up to $500,000 each for the 2020 grant cycle. The 2020 awards will focus on research in solid tumors – with a preference for applications in glioblastoma and pancreatic cancer.

Read More